Antimicrobial Agents and Chemotherapy · 2005 · 26 citations · 19 references
PharmacyMicrobiologyPharmacologyAntimicrobial PharmacotherapyHost-pathogen InteractionsMedical MicrobiologyAntifungal AgentsAntifungal PharmacotherapyAntifungal TherapyDrug Interactions With AntimicrobialsFungal InfectionsFungal PathogenesisAntifungal ChemotherapyAntifungal Drug InteractionsCandida Albicans InfectionCandida TherapyCell Survival CurvesConcomitant TherapyFungal Infection TreatmentFungal Infections In Immunocompromised Hosts
The interaction of posaconazole and amphotericin B was evaluated in concomitant treatment of Candida albicans systemic infections in immunocompetent mice by using four strains of C. albicans with different susceptibilities to fluconazole. Posaconazole and amphotericin B were each tested at four dose levels alone and in all possible combinations against each C. albicans strain. Survival curves of mice treated with combinations of posaconazole and amphotericin B were statistically compared with those of mice treated with the component monotherapies. Of the 64 total combinations evaluated against the C. albicans strains (16 combinations per strain), 20.3% were more effective in prolonging mouse survival than both of the monotherapies, 45.3% were more effective than one of the monotherapies, and 32.8% were similar to both monotherapies. No evidence of antagonism was observed between posaconazole and amphotericin B in this mouse model, consistent with in vitro results against the same strains.
19
Anthony Cacciapuoti, David Loebenberg, Erik Corcoran et al. · Antimicrobial Agents and Chemotherapy · 2000 · 99 citations · Full text
Medicine, Microbiology, Pharmacology +15
Russell E. Lewis, Randall A. Prince, Jingduan Chi et al. · Antimicrobial Agents and Chemotherapy · 2002 · 87 citations · Full text